What is Indivior PLC (INVVY)?

Indivior PLC (INVVY) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of INVVY?

The current price of INVVY is $21.85. Prices are updated in real time on Stocks360.

What is INVVY's price-to-earnings (PE) ratio?

INVVY's trailing twelve-month PE ratio is -60.68, based on current price and earnings per share data available on Stocks360.

What is INVVY's market capitalization?

INVVY's market capitalization is $3,012,035,869.00, placing it in the mid-cap tier.

Indivior PLC (INVVY)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$21.85

Market Cap

$3.01B

PE (TTM)

-60.68

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-0.06

Day Range

$21.85 – $21.85

52-wk Range

$14.76 – $75.65

Avg Volume

N/A

Volume

8.10K

Indivior PLC (INVVY) is a publicly traded company in the Healthcare sector. Latest price: $21.85. Market cap $3.01B. Trailing PE -60.68. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Indivior PLC

Indivior PLC, encompassing its various subsidiaries, is a pharmaceutical firm dedicated to the research, production, and global commercialization of prescription medications. These therapies primarily utilize buprenorphine to treat opioid dependence and associated medical conditions. The company's development pipeline is actively exploring novel treatments for opioid use disorder (OUD) and schizophrenia. Its current portfolio features the SUBLOCADE subcutaneous injection, along with sublingual formulations like SUBOXONE film, SUBOXONE tablets, and SUBUTEX tablets. Additionally, Indivior sells established products such as Temgesic, Burpex, and Buprenex. With operations spanning approximately 40 countries worldwide, the company also maintains a research collaboration agreement with Addex Therapeutics Ltd. Indivior PLC was founded in 2014 and is headquartered in North Chesterfield, Virginia.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-60.68×
P/S (TTM)	3.34×
P/B	59.54×
PEG	0.39×
P/FCF (TTM)	-301.20×
EV / EBITDA	-55.89×
EV / Sales	2.79×
Earnings Yield	-1.75%
Free Cash Flow Yield	-0.33%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$2.52B
Revenue (TTM)	$901.00M
Net Income (TTM)	-$52.57M
Free Cash Flow (TTM)	$6.18M
Net Debt	-$497.00M
Working Capital	$240.00M
Gross Margin	82.35%
Operating Margin	-10.10%
Net Margin	-5.88%
Return on Equity	-41.73%
Return on Invested Capital	-6.67%